Ready, set, resilience: Reassessing cyber resilience in the AI era
Regulators and authorities globally are advising organizations of the increasing risks posed by frontier AI models such as Claude Mythos. This begs the question: what are the essential steps to strengthen cyber defenses and remain operationally resilient amidst a transforming industry?
Regulatory Unwrapped: Innovation, regulation, revolution – which stage has AI reached?
Can firms retire lexicon-based monitoring? Is AI really just a cost and resource reduction tool? Find the answers to all this and more in episode two of Regulatory Unwrapped.
Regulatory Wrap episode 79: AI, AML, and Robocop
In Regulatory Wrap for the week to April 24, Jay Hampshire breaks down how FinCEN is encouraging firms to utilize AI-enabled tools to more effectively fight against financial crime.
AI is a “shiny new Ferrari” – can your compliance team drive it?
Compliance leaders visited the Global Relay offices to share their thoughts on integrating AI into compliance and monitoring frameworks and the steps firms can take to ensure successful implementation.
FINRA 2026 Oversight Report flags GenAI, recordkeeping, and cybersecurity risks
The regulator’s annual Oversight Report has highlighted GenAI, recordkeeping, cybersecurity, and third parties as areas where firms should focus efforts to strengthen compliance programs.
Navigating supply chain compliance in life sciences with emerging technologies
The healthcare and life sciences sector is experiencing a fundamental shift in how supply chains are tracked, verified, and documented. Behind this transinformation is a combination of regulatory pressure and technological innovation. Let’s take a look at how life sciences organizations can harness emerging technologies to mitigate risk and drive regulatory adherence.
EU AI Act
As a world-first, the EU’s Artificial Intelligence Act has been introduced as the most comprehensive AI regulation from August 2024 onwards. It is a direct response to the surge of unmonitored AI innovation and usage, which now present dangerous risks to end users and wider communities if misused.
What advice does the DOJ have for pharma compliance teams?
The DOJ assistant attorney general emphasized proactive self-disclosure and hinted at how pharmaceuticals can best prepare for new trends in enforcement.
Why use AI translation for compliance?
From increased efficiency, accuracy, and scalability to decreases in cost and security risk, AI-enabled translation and transcription is bringing a range of benefits to compliance and surveillance teams in highly regulated industries.
Building AI agents for tomorrow: A governance-first approach
Global Relay Group Product Manager, Chris Lau, tells us how the implementation of AI agents should lead with a governance-first approach, and sets out 12 considerations to build AI agents with future regulation in mind.
Cybersecurity compliance in healthcare: harnessing technology for regulatory compliance
As part of our ongoing series on B2B SaaS compliance solutions, today we’re exploring cybersecurity compliance: healthcare edition.